Table 3.
Rank | SNPs | |||
---|---|---|---|---|
50 | SNP_A-1879798 | SNP_A-4261939 | SNP_A-4288122 | SNP_A-1906431 |
100 | SNP_A-1781703 SNP_A-4254588 SNP_A-2291931 |
SNP_A-4257840 SNP_A-1827527 SNP_A-1893004 |
SNP_A-1990707 SNP_A-2272342 SNP_A-1859078 |
SNP_A-2092003 SNP_A-2264321 |
150 | SNP_A-4292799 SNP_A-2188211 |
SNP_A-4285002 SNP_A-4263960 |
SNP_A-2295075 | SNP_A-2176803 |
200 | SNP_A-4275514 SNP_A-4279597 |
SNP_A-4242077 SNP_A-4288260 |
SNP_A-2073412 SNP_A-4300538 |
SNP_A-1793920 |
250 | SNP_A-4258351 SNP_A-4269967 |
SNP_A-2207678 SNP_A-1811356 |
SNP_A-4277760 | SNP_A-1834280 |
300 | SNP_A-4258451 | SNP_A-4302014 | SNP_A-4293935 |
The 37 selected SNPs (probes) that exhibited significant difference between blood, and normal and tumor tissues, within the top N (= 50, 100, 150, 200, 250, and 300) outliers for both DNA methylation and genotype. Top 300 outliers are shown in red in Figures 6a and 6d. For detailed annotations, including associated genes, of the selected SNPs, see Additional file 1 (sheet name Sty2).